b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="In-Process" Owner="NLM">\n        <PMID Version="1">31764106</PMID>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>06</Month>\n            <Day>15</Day>\n        </DateRevised>\n        <Article PubModel="Print">\n            <Journal>\n                <ISSN IssnType="Electronic">1473-5571</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>33</Volume>\n                    <Issue>15</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>12</Month>\n                        <Day>01</Day>\n                    </PubDate>\n                </JournalIssue>\n                <Title>AIDS (London, England)</Title>\n                <ISOAbbreviation>AIDS</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>High incidence of tuberculosis in the first year of antiretroviral therapy in the Botswana National antiretroviral therapy programme between 2011 and 2015.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>2415-2422</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1097/QAD.0000000000002363</ELocationID>\n            <Abstract>\n                <AbstractText Label="OBJECTIVE">Tuberculosis (TB) remains one of the leading causes of mortality and morbidity among people living with HIV. We sought to estimate the incidence of TB in a national database of HIV-infected patients receiving antiretroviral therapy (ART) in Botswana.</AbstractText>\n                <AbstractText Label="DESIGN">A retrospective analysis of HIV-infected adult patients (\xe2\x89\xa518years) who initiated ART between 2011 and 2015 in the Botswana ART program.</AbstractText>\n                <AbstractText Label="METHODS">Multivariable analysis using Cox regression included sex, age, viral load and CD4 T-cell counts.</AbstractText>\n                <AbstractText Label="RESULTS">Of 45\xe2\x80\x8a729 patients, with a median follow-up of 1.7 years Q1 : Q3, 0.5, 3.1), 1791 patients developed TB over a median of 1.5 years (Q1 : Q3, 0.3, 3.1) of follow-up (incidence rate 1.9 per 100 person-years; 95% CI 1.8-2.0). At baseline, the median CD4 T-cell count was 272\xe2\x80\x8acells/\xce\xbcl (Q1, Q3 146, 403). The risk of TB was greatest within the first year of ART (incidence rate 2.9 per 100 person-years; 95% CI 2.7-3.1) and in patients with CD4 T-cell counts below 50\xe2\x80\x8acells/\xce\xbcl (incidence rate 8.3/100 person-years; 95% CI 7.1-9.7). Patients with viral loads above 10\xe2\x80\x8a000\xe2\x80\x8acopies/ml at 3 months post-ART initiation had two times higher risk of TB, hazard ratio 2.5 (95% CI 1.8-2.3).</AbstractText>\n                <AbstractText Label="CONCLUSION">We report a high incidence of TB within the first year of ART and in patients with advanced immunodeficiency. Improved screening strategies and virologic monitoring during this early period on ART, coupled with TB preventive treatment, will reduce the burden of TB.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Mupfumi</LastName>\n                    <ForeName>Lucy</ForeName>\n                    <Initials>L</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medical Laboratory Sciences, School of Allied Health Professions, University of Botswana.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Moyo</LastName>\n                    <ForeName>Sikhulile</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Immunology &amp; Infectious Diseases, Harvard TH Chan School of Public Health, Boston, Massachusetts.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Shin</LastName>\n                    <ForeName>Sanghyuk S</ForeName>\n                    <Initials>SS</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Sue &amp; Bill Gross School of Nursing, University of California Irvine, California.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Wang</LastName>\n                    <ForeName>Qiao</ForeName>\n                    <Initials>Q</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Immunology &amp; Infectious Diseases, Harvard TH Chan School of Public Health, Boston, Massachusetts.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Zetola</LastName>\n                    <ForeName>Nicola</ForeName>\n                    <Initials>N</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Infectious Diseases Division, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Botswana - University of Pennsylvania Partnership.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Molebatsi</LastName>\n                    <ForeName>Kesaobaka</ForeName>\n                    <Initials>K</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Statistics, University of Botswana.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Nnawa</LastName>\n                    <ForeName>Judith</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Health Policy Development Monitoring &amp; Evaluation, Ministry of Health &amp; Wellness.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Kgwaadira</LastName>\n                    <ForeName>Botshelo T</ForeName>\n                    <Initials>BT</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>National TB Program, Ministry of Health &amp; Wellness, Gaborone, Botswana.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Bewlay</LastName>\n                    <ForeName>Lesedi</ForeName>\n                    <Initials>L</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Tau Technology, Gaborone, Botswana.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Chebani</LastName>\n                    <ForeName>Tony</ForeName>\n                    <Initials>T</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Health Policy Development Monitoring &amp; Evaluation, Ministry of Health &amp; Wellness.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Iketleng</LastName>\n                    <ForeName>Thato</ForeName>\n                    <Initials>T</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>College of Health Sciences, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Mogashoa</LastName>\n                    <ForeName>Tuelo</ForeName>\n                    <Initials>T</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medical Laboratory Sciences, School of Allied Health Professions, University of Botswana.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Makhema</LastName>\n                    <ForeName>Joseph</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Immunology &amp; Infectious Diseases, Harvard TH Chan School of Public Health, Boston, Massachusetts.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Musonda</LastName>\n                    <ForeName>Rosemary M</ForeName>\n                    <Initials>RM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Immunology &amp; Infectious Diseases, Harvard TH Chan School of Public Health, Boston, Massachusetts.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Essex</LastName>\n                    <ForeName>Max</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Immunology &amp; Infectious Diseases, Harvard TH Chan School of Public Health, Boston, Massachusetts.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Kasvosve</LastName>\n                    <ForeName>Ishmael</ForeName>\n                    <Initials>I</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medical Laboratory Sciences, School of Allied Health Professions, University of Botswana.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Gaseitsiwe</LastName>\n                    <ForeName>Simani</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Immunology &amp; Infectious Diseases, Harvard TH Chan School of Public Health, Boston, Massachusetts.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <GrantList CompleteYN="Y">\n                <Grant>\n                    <GrantID>D43 TW010543</GrantID>\n                    <Acronym>TW</Acronym>\n                    <Agency>FIC NIH HHS</Agency>\n                    <Country>United States</Country>\n                </Grant>\n                <Grant>\n                    <GrantID>107752/Z/15/Z</GrantID>\n                    <Acronym>WT_</Acronym>\n                    <Agency>Wellcome Trust</Agency>\n                    <Country>United Kingdom</Country>\n                </Grant>\n            </GrantList>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D013485">Research Support, Non-U.S. Gov\'t</PublicationType>\n                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>\n            </PublicationTypeList>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>England</Country>\n            <MedlineTA>AIDS</MedlineTA>\n            <NlmUniqueID>8710219</NlmUniqueID>\n            <ISSNLinking>0269-9370</ISSNLinking>\n        </MedlineJournalInfo>\n        <CitationSubset>IM</CitationSubset>\n        <CitationSubset>X</CitationSubset>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>11</Month>\n                <Day>26</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>11</Month>\n                <Day>26</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>11</Month>\n                <Day>26</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31764106</ArticleId>\n            <ArticleId IdType="doi">10.1097/QAD.0000000000002363</ArticleId>\n            <ArticleId IdType="pii">00002030-201912010-00014</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'